|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:administeredBy
|
Prescription medication
Illicit drug
|
|
gptkbp:affects
|
gptkb:Perception
gptkb:Central_nervous_system
emotion
Cognition
Behavior
|
|
gptkbp:canBe
|
Natural
Synthetic
Addictive
Non-addictive
|
|
gptkbp:cause
|
Tolerance
Dependence
Withdrawal symptoms
|
|
gptkbp:class
|
Chemical structure
Pharmacological effect
|
|
gptkbp:example
|
gptkb:Nicotine
gptkb:beer
gptkb:Cocaine
gptkb:Amphetamine
gptkb:Diazepam
gptkb:Ketamine
gptkb:Psilocybin
gptkb:MDMA
gptkb:Benzodiazepines
gptkb:Fluoxetine
gptkb:Barbiturates
gptkb:Opioids
LSD
Cannabis
Caffeine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Psychotropic substances
|
|
gptkbp:includes
|
gptkb:Antidepressants
gptkb:Hallucinogens
Anxiolytics
Antipsychotics
Mood stabilizers
Stimulants
Hypnotics
Sedatives
|
|
gptkbp:listedOn
|
gptkb:UN_Convention_on_Psychotropic_Substances
|
|
gptkbp:may_be_used_for
|
Religious rituals
Recreational purposes
Medical purposes
|
|
gptkbp:regulates
|
gptkb:United_Nations
gptkb:Controlled_Substances_Act_(USA)
|
|
gptkbp:studiedBy
|
gptkb:Psychopharmacology
|
|
gptkbp:usedFor
|
Treatment of mental disorders
|
|
gptkbp:bfsParent
|
gptkb:Controlled_Substances_Schedules_I-V
|
|
gptkbp:bfsLayer
|
7
|